% Expired Patents = 33.3

Trademarks = 1

Forward Citations = 107

Loading Chart...

6 inventors (with patents filed for the assignee):

Stan Gronthos (9 out of 20 patents)

Andrew Zannettino (7 out of 12 patents)

Paul J Simmons (6 out of 10 patents)

4. Andrew Christopher William Zannettino (2 out of 5 patents)

5. Songtao Shi (1 out of 15 patents)

6. John Paul Simmons (1 out of 2 patents)

9 patents: Sort by Forward Citations

1. 9815896 - Monoclonal antibody STRO-4 (2017-11-14),

2. 9783617 - Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase (2017-10-10),

3. 8546138 - Mesenchymal precursor cell (2013-10-01),

4. 8158118 - Mesenchymal precursor cell (2012-04-17),

5. 8062675 - Mesenchymal precursor cell (2011-11-22),

6. 7947266 - Perivascular mesenchymal precursor cells (2011-05-24),

7. 7670628 - Mesenchymal precursor cell (2010-03-02),

8. 7399632 - Mesenchymal precursor cell (2008-07-15),

9. 7122178 - Mesenchymal precursor cell (2006-10-17),

Company Overview

Angioblast Systems, Inc. is a biotechnology company focused on developing innovative stem cell therapies for cardiovascular diseases. Our proprietary technology platform allows us to create therapeutic cell products that have the potential to regenerate damaged heart tissue and improve patient outcomes. With a deep commitment to scientific excellence and patient care, Angioblast aims to revolutionize the treatment of heart disease.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#762 in NEW YORK, NY

#1,901 in New York

#32,565 in US

NEW YORK, NY, United States of America

Angioblast Systems, Inc.

Forward Citations = 107

6 inventors:

Stan Gronthos (9 out of 20 patents)

Andrew Zannettino (7 out of 12 patents)

Paul J Simmons (6 out of 10 patents)

4. Andrew Christopher William Zannettino (2 out of 5 patents)

5. Songtao Shi (1 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angioblast Systems, Inc.. Retrieved from https://idiyas.com/company/angioblast-systems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]